COL18A1 and cancer: The fact that low endostatin serum levels and the presence of autoantibodies to endostatin are associated with a better survival is puzzling, as endostatin is supposed to act as an inhibitor of angiogenesis, tipping the balance of the angiogenic switch towards the ‘off’ position, thus inhibiting cancer progression.